WCG adds clinical trial benchmarking firms to portfolio

25-Jul-2018 - Last updated on 25-Jul-2018 at 20:46 GMT

(Image: Getty/Kritchanut)

WCG’s acquisition of KMR Group and MCC addresses sponsor and CRO need to establish a common set of metrics to understand and manage clinical trial performance, says CEO.

KMR Group and Metrics Champion Consortium (MCC) will operate independently as part of the WIRB-Copernicus Group (WCG) Market Insights and Intelligence Division. The firms provide benchmarking, metrics, analytics and performance management in the clinical research and development space.

WCG will support the companies with access to capital, expertise, and corporate operational support, according to the clinical services organization.

“The sheer volume of clinical trial performance data available to sponsors and CROs has exploded over the past few years and many clinical trial leaders are struggling to operationalize these data in a consistent and actionable manner,” said Donald A. Deieso, PhD, executive chairman and CEO of WCG.

To keep up, Deieso told us “sponsors and CROs need to establish a common set of metrics to understand and manage clinical trial performance.”

“By bringing together these leading companies, we can address the growing need to establish standardized data benchmarks across the most critical areas of R&D and clinical trial execution.”